Clik here to view.
First Hepatitis-C Center in Northeast Region Established By Rockefeller...
New York, NY–Three neighboring New York City medical institutions–The Rockefeller University, NewYork-Presbyterian Hospital, and Weill Medical College of Cornell University–have jointly established the...
View ArticleClik here to view.
Researchers Identify Key to Genetic Replication in Hepatitis C Virus
Researchers at Rockefeller University and Washington University School of Medicine in St. Louis have identified mutations in a protein of certain strains of hepatitis C virus (HCV) that allow these...
View ArticleTwo Rockefeller scientists elected to National Academy of Sciences
The National Academy of Sciences announced the election of 72 new members this morning, including two Rockefeller University scientists. More »
View ArticleResearchers create infectious hepatitis C virus in a test tube
New system will allow scientists to study every stage of the HCV life cycle and develop drugs to treat this life-threatening disease. More »
View ArticleClik here to view.
Building a better vaccine
By studying how the yellow fever vaccine creates a potent, lifelong immunity after a single shot, Rockefeller scientists say they could unlock secrets that will help design new vaccines to target not...
View ArticleResearchers show laboratory hepatitis C strain is also infections in animal...
For many years scientists have struggled with an inability to efficiently culture the hepatitis C virus in the laboratory. Now, researchers at Rockefeller University have overcome several obstacles and...
View ArticleClik here to view.
Kety protein for Hepatitis C entry identified
For as many as 200 million people worldwide infected with hepatitis C, a leading cause of chronic liver disease, treatment options are only partially effective. But new research by Rockefeller...
View ArticleHepatitis C virus blocks ‘superinfection’
There’s infection and then there’s superinfection – when a cell already infected by a virus gets a second viral infection. But some viruses don’t like to share their cells. New research from...
View ArticleNew theory suggests how hepatitis C may cause rare immune disease
In 1990 researchers observed that most patients with hepatitis C also develop a rare autoimmune disease called mixed cryoglobulinemia, a condition that frequently leads to cancer, arthritis or both....
View ArticleClik here to view.
By imaging living cells, researchers show how hepatitis C replicates
The hepatitis C virus is a prolific replicator, able to produce up to a trillion particles per day in an infected person. By using live imaging, researchers now know how. Their research shows that...
View ArticleClik here to view.
Discovery could lead to a new animal model for hepatitis C
The hepatitis C virus is interested in only one thing: human liver cells. That has been one of scientists’ greatest frustrations in their efforts to study the virus, and has hampered the development of...
View ArticleMultitasking may be Achilles heel for hepatitis C
Hepatitis C, a formidable virus that affects 130 million people worldwide, is nursing some pretty impressive bruises. By knocking out sections and subsections of one of its proteins, scientists reveal...
View ArticleClik here to view.
Scientists visualize how a vital hepatitis C virus protein moves along its...
In a series of three snapshots that recapitulate the coordinated actions, scientists reveal how a protein essential for the replication of the hepatitis C virus moves along its nucleic acid substrate....
View ArticleClik here to view.
Researchers modify yellow fever vaccine to fight malaria
A genetically modified vaccine originally used to eradicate yellow fever could be the key to stopping a mosquito-borne scourge that afflicts much of the developing world. More »
View ArticleClik here to view.
Scientists create humanized mouse model for hepatitis C
A team of researchers led by scientists in the Laboratory of Virology and Infectious Disease at Rockefeller have, for the first time, recreated a portion of the hepatitis C virus life cycle in a mouse...
View ArticleClik here to view.
Key to blocking influenza virus may lie in a cell’s own machinery
Researchers have found that the immune system fights a flu infection by turning off cellular enzymes the virus needs to put the final touches on new viral particles. The unfinished particles cannot...
View ArticleClik here to view.
A virus common among livestock depends on a microRNA to replicate
Increasingly, scientists are finding that small RNA molecules might be effective targets for antiviral drugs. Using a new screening method, Rockefeller researchers now show that a number of RNA...
View ArticleClik here to view.
Charles Rice wins Belgium’s highest scientific prize
Rice has received the 2016 InBev-Baillet Latour Health Prize for his fundamental discoveries in the field of infectious diseases. The award, given by the Baillet Latour Fund to recognize outstanding...
View ArticleClik here to view.
Charles M. Rice wins Lasker Award for groundbreaking work on the hepatitis C...
This year’s Lasker-DeBakey Clinical Medical Research Award honors Charles M. Rice, who developed a system to study the replication of the virus that causes hepatitis C, an advance that has led to safe...
View ArticleIn the News – New York Times – Rice
Lasker Awards Given for Work in Physiology, Virology and Science Education “At the time, researchers thought the work might be as simple as inserting that newly sequenced RNA into cultured cells and...
View Article
